The CDC warns of disrupted access to care for ADHD patients due to the federal indictment of two Done Global executives, affecting a significant number of patients.
The indictment accuses the executives of a scheme to distribute Adderall, committing fraud, and generating over $100 million in revenue.
These disruptions from a prominent telehealth company can affect up to 50,000 ADHD patients across all 50 U.S. states.
Patients relying on prescription stimulants may face treatment interruptions and lack of access to care as a result of the executives' arrest.
[
add
]
[
|
|
...
]